The objective of this study was to analyse the relationship between the ambulatory blood pressure (ABP) measurement and plasma adiponectin levels in a population-based cohort. Non-hypertensive, non-diabetics from the Oulu Project Elucidating Risk of Atherosclerosis cohort aged 40-60 years with ABP measurement available in 226 men and 236 women were analysed. ABP was recorded using the fully automatic SpaceLabs 90207 oscillometric unit. Plasma adiponectin concentrations were assayed using the enzyme-linked immunosorbent assay method. Without adjustment the highest plasma adiponectin tertile was associated with the lowest ABP and office BP measurements (P from 0.025 to Po0.001, respectively). Only the association of plasma adiponectin concentration with systolic ABP was independent of other conventional risk factors (age, body mass index (BMI), waist, gender, insulin sensitivity index, smoking and alcohol consumption) for hypertension (P ¼ 0.017). No association was observed between systolic dipping pattern and adiponectin level. The plasma high adiponectin concentration is independently associated with low daytime systolic ABP value. The mechanisms may include effects on endothelial function and the sympathetic nervous system.
Introduction
Adiponectin is an adipokine that is secreted specifically from adipose tissue. 1 The association between a low plasma adiponectin level and an unfavourable metabolic and cardiovascular profile has been shown in several studies. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] The adiponectin level is reduced in subjects with hypertension 9, 11, 12 and the reduced adiponectin level has been claimed to be an independent risk factor for hypertension in cross-sectional studies. 13 The biological mechanisms responsible for the association of the reduced adiponectin level with higher blood pressure are not known at present 5 and the specific biological role of adiponectin still awaits clarification. 14 It is possible that only under metabolic or cellular stress conditions is a reduction or a lack of adiponectin associated with deleterious consequences. 5 Most of the studies examining adiponectin and blood pressure have been conducted in hypertensive or diabetic subjects. There are only a few studies concerning the association between adiponectin and blood pressure in the non-hypertensive, non-diabetic population. In a study examining 68 non-diabetic adolescent females, an association was noted between adiponectin and both the office systolic (SBP) and diastolic blood pressure (DBP). After adjustment for confounding factors, the association still remained significant between SBP and adiponectin, but not between DBP and adiponectin. 14 Recently, Sung et al. 12 in their communitybased survey of 2045 residents aged X40 years found that adiponectin was independently associated with SBP and DBP in a subgroup of their 1512 non-diabetic, non-hypertensive population.
In recent years, there has been a growing interest in ambulatory blood pressure (ABP) measurement for both clinical and research purposes. It was shown in a large cross-sectional study by Ohasama 15, 16 that the mortality risk was increased in the highest quintile of average 24-h BP. One limitation of the Ohasama study was the lack of statistical adjustment for diabetes and the serum cholesterol levels. 17 A reduction in blood pressure by 410% or 410/5 mm Hg from daytime to night-time is called the dipping pattern and is considered to be normal.
A reduction lesser than that value is called the nondipping pattern and shows a correlation between cardiovascular and stroke end points and also with the progression of renal damage. [18] [19] [20] [21] Although it is a somewhat artificial dichotomization of a continuous variable, it is considered to be clinically relevant. In some subjects, although they are normotensive at daytime, the normal nocturnal drop in blood pressure is o10%. It has been shown that the lack of nocturnal blood pressure drop (non-dipping pattern) is associated with target organ involvement. 22, 23 There are many reasons that may account for this phenomenon: high level of daytime activity, sleep problems, high sympathetic nervous activity, use of glucocorticoids and the presence of renal disease. 24, 25 Previously, the relationship between hypertension, adiponectin and dipping status has been analysed in patients with essential hypertension, 26 but this association has not been studied in normotensive subjects. The purpose of this study was to analyse the relationship between ABP measurement values and the plasma adiponectin level measured in a large population-based cohort (n ¼ 526) without diagnosed hypertension.
Subjects and methods

Subjects
The Oulu Project Elucidating Risk of Atherosclerosis is a population-based epidemiological casecontrol study addressing the risk factors and disease end points of atherosclerotic cardiovascular diseases. The study population and selection criteria have been previously described in detail. 27 The study design is cross-sectional. The study population consists of a hypertensive cohort (300 men and 300 women) and a control cohort (300 men and 300 women), 40-59 years old at the time of recruitment (1 September 1990) and residents in the city of Oulu. The hypertensive cohort was randomly selected by age stratification (15 men and 15 women per year) from the Social Insurance Institute register for reimbursement of antihypertensive medication. For each hypertensive subject, an age-and sex-matched control was randomly selected from the national health register (including all inhabitants) excluding the subjects with the right to reimbursement for hypertension medication. This study focuses on the control cohort (n ¼ 600) from which 526 subjects (87%) went through the study protocol. This group consisted of 259 men and 267 women. The 24-h ABP measurement was available in 226 men and 236 women.
The selected subjects were recruited by an invitation letter to participate in the study, and one reminder letter was sent when necessary. The letters were mailed by the Social Insurance Institution. The first invitations were mailed at the end of 1990. The participating study subjects visited the research laboratory of the Department of Internal Medicine of the University of Oulu between January 1991 and March 1993, starting with the men (during 1991 and early 1992) and then the women.
A total of 26 men and 29 women among the control subjects were receiving some chronic medication affecting BP. The medication was mainly a b-blocker or a diuretic and it was in use because of some reason other than hypertension (palpitation, oedema or tremour). The analysis was made both with and without the medicated subjects. The medication did not affect the results.
Alcohol consumption was determined in an extensive interview that asked about the amount of beer, wine and strong alcoholic beverages consumed. This was estimated as grams of absolute alcohol per week and smoking as the number of cigarettes smoked per day, which was then converted to packs per year. 28, 29 Blood pressure measurements The office BP was measured with an automatic oscillometric recorder (Dinamap model 18465X, Criticon Ltd., Ascot, UK). The subjects were seated for at least 5 min, after which the BP was measured thrice at 1-min intervals. The mean of the second and third measurement was used for the analysis. 30 Ambulatory blood pressure was recorded using the fully automatic SpaceLabs 90207 oscillometric unit (SpaceLabs Inc., Redmond, WA, USA), which was set to take a measurement every 15 min from 0400 h till midnight and every 20 min from midnight till 0400 h. The accuracy and reproducibility of the BP readings obtained with this device have been established previously by The British Hypertension Society and the US Association for the Advancement of Medical Instrumentation. 31 The proper positioning of the cuff in each case was ensured by means of the similarity (difference of o5 mm Hg) between four SpaceLabs BP measurements and four auscultatory readings using a Y-connector. The subjects were asked to relax their arm during the measurement. Values of SBP o70 or 4250 mm Hg, DBP o40 or 4150 and heart rate o40 or 4150 beats per minute were automatically excluded from the analysis. Fewer than 3% of the BP readings were rejected as artefacts on the basis of these criteria. 32 A reduction in SBP from daytime to night-time of o10% was considered to represent a non-dipping pattern.
Laboratory analyses
All laboratory samples were obtained after an overnight fast, and plasma was separated by centrifugation and stored at À20 1C. Most of the laboratory analyses were carried out within 2 days after the blood sampling. The clinical laboratory tests were carried out in the Central Laboratory of Oulu University Hospital and research laboratory of the Department of Internal Medicine of the University of Oulu as described before. 29 Plasma adiponectin was measured from 458 subjects after an overnight fast. Plasma adiponectin concentrations were measured with the enzyme-linked immunosorbent assay method previously described by Santaniemi et al.
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The intra-assay variation of method was 13.9%, and the interassay variation was 15.9% before and 6.5% after correction.
The plasma insulin concentration was analysed with the double RIA method (AIA-PACK IRI, Tosoh Corp., Tokyo, Japan). The venous blood glucose concentration was determined with the glucose dehydrogenase method.
Insulin sensitivity was assessed using a quantitative insulin sensitivity check index (QUICKI ¼ 1/[log (fasting insulin) þ log (fasting glucose)]).
Statistical methods
Baseline characteristics of the study population are given as means and s.d. The blood pressure dipping was defined as a day-to-night systolic decrease of X10% according to the commonly accepted criteria. 18, 24 Plasma adiponectin, body mass index (BMI) and ABP values showed skewness as continuous variables and were logarithmically transformed to achieve a normal distribution. Analysis of covariance was used to compare the means of more than two groups (that is, between the adiponectin tertiles). The following variables were entered as covariates: gender, age, BMI, alcohol consumption and smoking (pack-years). Statistical analysis was made using SPSS version 16.0. A Pvalue of o0.05 was considered statistically significant. The studies were considered exploratory in nature and no correction was made for multiple testing.
Results
A total of 458 subjects, 222 men and 236 women, were examined in this study. The main characteristics of this population are shown in Table 1 .
The mean age of the cohort was 51 years and there was no statistical difference in age between the genders. Men seemed to be more often smokers and alcohol consumption was also higher among men. Furthermore, the men were more abdominally obese according to the mean waist circumference (Po 0.001). The difference in plasma adiponectin was statistically significant between genders (Po0.001) with women having a markedly higher adiponectin concentration. Both office SBP and DBP values were higher in men than in women (Po0.001), whereas heart rate at the same time was slightly but significantly higher in females (P ¼ 0.011).
With respect to the mean 24-h blood pressure values, SBP and DBP during daytime (Po ¼ 0.001) and night-time (Po0.001) were higher in men than in women. The difference was still statistically significant after the adjustment for BMI (Po0.001). Women showed a higher mean 24-h heart rate value during daytime (P ¼ 0.021) and tended (P ¼ 0.05) to have a higher heart rate during night. Overall, 17.6% of male and 19.9% of female subjects (not significant) belonged to the group of non-dippers.
Plasma adiponectin and blood pressure variables
Plasma adiponectin values were divided into tertiles and blood pressure parameters were analysed in these three groups. Without adjustment, plasma adiponectin tertiles were associated with all ABP and office BP measurements (P-values ranging from 0.025 to Po0.001; Table 2 ). This association was characterized by the highest adiponectin tertile showing the lowest BP. Only the association of the plasma adiponectin concentration with systolic ABP was independent of the other conventional risk factors for hypertension. This relationship was supported by the fact that adjustment of systolic but not diastolic ABP measurements for age, BMI, waist, gender, smoking and alcohol consumption did not change the association to a nonsignificant level (P ¼ 0.017; Figure 1 ).
To explore whether the association between plasma adiponectin level and mean systolic ABP is mediated through its effect on insulin sensitivity, we made a further adjustment for quick index but the association still remained significant (P ¼ 0.029). We found no association between heart rate and adiponectin.
The analyses were further carried out in males and females separately. There was a negative association between plasma adiponectin and mean ambulatory daytime SBP of females before (P ¼ 0.016) and after adjustments (P ¼ 0.040), whereas no such association was found in males (P ¼ 0.178 and P ¼ 0.260, respectively).
Dipping pattern and adipokines
No association between systolic dipping pattern and adiponectin was observed. The latter association was analysed before and after the adjustment for age, BMI, waist, gender, smoking and alcohol consumption.
Discussion
In this study we analysed a large population of middle-aged Finnish men and women to determine whether plasma adiponectin levels are associated with ABP measurements. There are no previous data concerning ABP and plasma adiponectin levels in a non-hypertensive, non-diabetic adult population. The results indicated that a high adiponectin concentration was independently associated with low ABP daytime systolic value. When the genders were considered separately, the association was observed in females but not in their male counter-parts. The association with daytime DBP was not so clear as it disappeared after adjustment. Furthermore, plasma adiponectin levels were not associated with dipping status.
What might be the mechanisms linking low adiponectin and elevated ABP? It is known that adiponectin has beneficial effects on vascular function. 1, 3, 5 It influences the functions of endothelial cells and smooth muscle cells, which are two main cell types relevant to blood pressure regulation. 33 Plasma adiponectin concentrations have been shown to correlate with endothelium-dependent vasodilatation in both diabetic and non-diabetic population. Therefore, adiponectin may have a critical role in maintaining endothelial function and vascular tone. 34 It increases nitric oxide production and low levels have been shown to be closely related to vessel endothelial dysfunction. 1, 2, 9, 11, 35, 36 A decrease in the plasma adiponectin concentration may impair various physiological functions of endothelial cells. 3 Moreover, hypoadiponectinaemia attenuates growth factor-induced proliferation of vascular smooth muscle cells and may lead to hypertension through the development of vascular hypertrophy and stiffness. 9 It is believed that hypoadiponectinaemia is associated with early atherosclerotic vascular damage that leads to endothelial dysfunction.
Sympathetic nervous system overdrive has been shown to suppress adiponectin expression in mice. 36 With a lower level of adiponectin, the compensatory mechanisms in resistance vessels might be weaker leading to higher BP. The daytime elevated sympathetic activity may lead to higher ambulatory daytime SBP to which low adiponectin might be exposed. Evidence has been provided that adiponectin can inhibit the activation of sympathetic nervous system through its central nervous system actions. 37 SBP might be an informative indicator considering the cardiovascular risk as isolated SBP has been associated with increased mortality risk in several studies, especially in the middle-aged population. 38 Hypoadiponectinaemia is related to the development of insulin resistance. 7 Therefore, the effect of high adiponectin on SBP may be mediated through lowering of insulin resistance. However, the association between systolic ABP and low plasma adiponectin level remained significant after adjustment for the insulin sensitivity index, which is consistent with the concept that it is not dependent on the level of insulin resistance. There is evidence that adiponectin can exert an effect directly on the vascular system in the absence of coexisting insulin resistance. 39 Adiponectin levels are decreased in obesity and hypertension is more common among obese individuals. 40 Kazumi et al. 13 showed that young, healthy Japanese male college students with high-normal SBP and DBP in office had lower serum adiponectin concentrations after adjustment for BMI. In addition, Huang et al. 14 showed a relationship between plasma adiponectin and SBP taken as an office measurement in healthy nondiabetic female adolescents. After the adjustment for anthropometric measurements, the association still remained with SBP but not with DBP. These findings are in accordance with the results of this study that extends them to the whole daytime SBP.
The limitations of the study are related to the cross-sectional nature of the data. It must also borne in mind that the ABP consisted of only one measurement. It is also possible that the measurements disturb the daily routines especially when made for the first time. The lack of a patient diary considering the ABP measurement period is also a weakness, in which case we could have obtained information about possible daytime naps or sleeping problems. Another limitation of the study was that we were able to measure only the total adiponectin level instead of its different fractions.
In conclusion, our study detected an independent association between hypoadiponectinaemia and daytime SBP in a non-hypertensive, non-diabetic cohort aged 40-60 years. There was no association between the systolic dipping pattern and adiponectin level. In will be important to examine this cohort again in the future for determining the clinical relevance of this finding in a prospective follow-up study.
